Insiders · Profile

Pomerantz Roger

President and CEO at Seres Therapeutics. Filing since 1 Apr 2016. CIK 0001614936

Company

Date

Role

Action

Shares

Amount

Of holding

MCRB Seres Therapeutics, Inc.

7 Sep 2018

President and CEO

Sold, plan not stated

1,810

$16.29K

0.8%

MCRB Seres Therapeutics, Inc.

6 Sep 2018

President and CEO

Sold, plan not stated

3,013

$27.24K

1.4%

MCRB Seres Therapeutics, Inc.

5 Sep 2018

President and CEO

Sold, plan not stated

9,505

$86.71K

4.2%

MCRB Seres Therapeutics, Inc.

11 Jul 2018

President and CEO

Sold, plan not stated

1,010

$9.10K

0.4%

MCRB Seres Therapeutics, Inc.

10 Jul 2018

President and CEO

Sold, plan not stated

5,989

$54.21K

2.6%

MCRB Seres Therapeutics, Inc.

9 Jul 2018

President and CEO

Sold, plan not stated

10,981

$100.35K

4.6%

MCRB Seres Therapeutics, Inc.

6 Jul 2018

President and CEO

Sold, plan not stated

15,366

$140.51K

6.3%

MCRB Seres Therapeutics, Inc.

29 Jun 2018

President and CEO

Sold, plan not stated

4,496

$40.92K

1.9%

MCRB Seres Therapeutics, Inc.

28 Jun 2018

President and CEO

Sold, plan not stated

21,560

$197.38K

8.6%

MCRB Seres Therapeutics, Inc.

27 Jun 2018

President and CEO

Sold, plan not stated

16,991

$153.41K

6.9%

MCRB Seres Therapeutics, Inc.

26 Jun 2018

President and CEO

Sold, plan not stated

21,224

$195.13K

8.5%

MCRB Seres Therapeutics, Inc.

25 Jun 2018

President and CEO

Sold, plan not stated

26,752

$246.50K

10.5%

MCRB Seres Therapeutics, Inc.

22 Jun 2018

President and CEO

Sold, plan not stated

40,057

$374.76K

14.4%

MCRB Seres Therapeutics, Inc.

21 Jun 2018

President and CEO

Sold, plan not stated

18,987

$172.09K

6.4%

MCRB Seres Therapeutics, Inc.

20 Jun 2018

President and CEO

Sold, plan not stated

26,492

$247.05K

8.2%

MCRB Seres Therapeutics, Inc.

9 May 2018

President and CEO

Sold, plan not stated

233

$2.10K

0.1%

MCRB Seres Therapeutics, Inc.

27 Jul 2016

President and CEO

Sold, plan not stated

20,000

$700.00K

9.8%

MCRB Seres Therapeutics, Inc.

6 Jul 2016

President and CEO

Sold, plan not stated

35,435

$1.05M

16.2%

MCRB Seres Therapeutics, Inc.

5 Jul 2016

President and CEO

Sold, plan not stated

52,776

$1.55M

22.3%

MCRB Seres Therapeutics, Inc.

1 Jul 2016

President and CEO

Sold, plan not stated

56,789

$1.69M

23.6%

MCRB Seres Therapeutics, Inc.

2 Jun 2016

President and CEO

Sold, plan not stated

74,049

$2.41M

28.7%

MCRB Seres Therapeutics, Inc.

1 Jun 2016

President and CEO

Sold, plan not stated

70,951

$2.16M

27.9%

MCRB Seres Therapeutics, Inc.

24 May 2016

President and CEO

Sold, plan not stated

9,801

$294.03K

5.1%

MCRB Seres Therapeutics, Inc.

6 May 2016

President and CEO

Sold, plan not stated

8,507

$206.80K

27.2%

MCRB Seres Therapeutics, Inc.

5 May 2016

President and CEO

Sold, plan not stated

30,027

$772.74K

56.9%

MCRB Seres Therapeutics, Inc.

4 May 2016

President and CEO

Sold, plan not stated

29,298

$777.54K

56.3%

MCRB Seres Therapeutics, Inc.

3 May 2016

President and CEO

Sold, plan not stated

23,680

$663.18K

51.0%

MCRB Seres Therapeutics, Inc.

2 May 2016

President and CEO

Sold, plan not stated

43,687

$1.27M

65.8%

MCRB Seres Therapeutics, Inc.

7 Apr 2016

President and CEO

Sold, plan not stated

9,212

$276.36K

28.8%

MCRB Seres Therapeutics, Inc.

4 Apr 2016

President and CEO

Sold, plan not stated

44,825

$1.30M

66.4%

MCRB Seres Therapeutics, Inc.

1 Apr 2016

President and CEO

Sold, plan not stated

90,963

$2.40M

80.0%

31 decisions on file.